A Flow Cytometry-Based Assay for Procoagulant Platelet Polyphosphate

Cytometry Part B - Clinical Cytometry

Volumn 94, Issue 2, 2018, Pages 369-373

  Labberton, Linda ^a,b   Long, Andy T ^b   Gendler, Sandra J ^c   Snozek, Christine L ^d   Stavrou, Evi X ^e,f   Nickel, Katrin F ^a,b   Maas, Coen ^g   Blankenberg, Stefan ^h   Hernandez, James S ^d   Renné, Thomas ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MAYO GRADUATE SCHOOL   (United States)

^d MAYO CLINIC   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

biomarker; flow cytometry; platelets; polyphosphate

Indexed keywords

ADENOSINE DIPHOSPHATE; FLUORESCENT DYE; POLYPHOSPHATE; PROCOAGULANT; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; ACID ANHYDRIDE HYDROLASE; BACTERIAL PROTEIN; PPX PROTEIN, ESCHERICHIA COLI; THROMBIN;

ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOCYTE RICH PLASMA; BLOOD CLOTTING; CELL MEMBRANE; METABOLISM; PHYSIOLOGY; PROCEDURES;

ACID ANHYDRIDE HYDROLASES; BACTERIAL PROTEINS; BLOOD COAGULATION; BLOOD PLATELETS; CELL MEMBRANE; FLOW CYTOMETRY; HUMANS; PLATELET ACTIVATION; POLYPHOSPHATES; THROMBIN;

EID: 85006109808     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21492     Document Type: Article

References (32)

1. Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008;451:914–918.
2. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227–1234.
3. Renne T, Schmaier AH, Nickel KF, Blomback M, Maas C. In vivo roles of factor XII. Blood 2012;120:4296–4303.
4. Back J, Sanchez J, Elgue G, Ekdahl KN, Nilsson B. Activated human platelets induce factor XIIa-mediated contact activation. Biochem Biophys Res Commun 2010;391:11–17.
5. Johne J, Blume C, Benz P, Pozgajová M, Ullrich M, Schuh K, Nieswandt B, Walter U, Renné T. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Biol Chem 2006;387:173–178.
6. Walsh PN, Griffin JH. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood 1981;57:106–118.
7. Castaldi PA, Larrieu MJ, Caen J. Availability of platelet Factor 3 and activation of factor XII in thrombasthenia. Nature 1965;207:422–424.
8. Pluthero FG, Ryan C, Williams S, Brandao LR, Kahr WH. Decreased in vitro thrombin generation and clot stability in human FXII-null blood and plasma. Br J Haematol 2011;152:111–112.
9. Labberton L, Kenne E, Renne T. New agents for thromboprotection. A role for factor XII and XIIa inhibition. Hamostaseologie 2015;35:338–350.
10. Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renné T. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009;139:1143–1156.
11. Larsson M, Rayzman V, Nolte MW, Nickel KF, Björkqvist J, Jämsä A, Hardy MP, Fries M, Schmidbauer S, Hedenqvist P, Broomé M, Pragst I, Dickneite G, Wilson MJ, Nash AD, Panousis C, Renné T. A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci Transl Med 2014;6:222ra217
12. Rao NN, Gomez-Garcia MR, Kornberg A. Inorganic polyphosphate: Essential for growth and survival. Annu Rev Biochem 2009;78:605–647.
13. Ruiz FA, Lea CR, Oldfield E, Docampo R. Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem 2004;279:44250–44257.
14. Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, Morrissey JH. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 2010;116:4353–4359.
15. Björkqvist J, de Maat S, Lewandrowski U, Di Gennaro A, Oschatz C, Schönig K, Nöthen MM, Drouet C, Braley H, Nolte MW, Sickmann A, Panousis C, Maas C, Renné T. Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III. J Clin Invest 2015;125:3132–3146.
16. Sala-Cunill A, Björkqvist J, Senter R, Guilarte M, Cardona V, Labrador M, Nickel KF, Butler L, Luengo O, Kumar P, Labberton L, Long A, Di Gennaro A, Kenne E, Jämsä A, Krieger T, Schlüter H, Fuchs T, Flohr S, Hassiepen U, Cumin F, McCrae K, Maas C, Stavrou E, Renné T. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. J Allergy Clin Immunol 2015;135:1031–1043.
17. Wat JM, Foley JH, Krisinger MJ, Ocariza LM, Lei V, Wasney GA, Lameignere E, Strynadka NC, Smith SA, Morrissey JH, Conway EM. Polyphosphate suppresses complement via the terminal pathway. Blood 2014;123:768–776.
18. Nickel KF, Spronk HM, Mutch NJ, Renne T. Time-dependent degradation and tissue factor addition mask the ability of platelet polyphosphates in activating factor XII-mediated coagulation. Blood 2013;122:3847–3849.
19. Labberton L, Kenne E, Long AT, Nickel KF, Di Gennaro A, Rigg RA, Hernandez JS, Butler L, Maas C, Stavrou EX, Renné T. Neutralizing blood-borne polyphosphate in-vivo provides safe thromboprotection. Nat Commun 2016;7:12616. doi: 10.1038/ncomms12616.
20. van Velzen JF, Laros-van Gorkom BAP, Pop GAM, van Heerde WL. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers. Thromb Res 2012;130:92–98.
21. Akiyama M, Crooke E, Kornberg A. An exopolyphosphatase of Escherichia coli the enzyme and its ppx gene in a polyphosphate operon. J Biol Chem 1993;268:633–639.
22. Golebiewska EM, Poole AW. Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev 2015;29:153–162.
23. + . J Biol Chem 2011;286:21073–21082.
24. Murugappan S, Tuluc F, Dorsam RT, Shankar H, Kunapuli SP. Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets. J Biol Chem 2004;279:2360–2367.
25. Morrissey JH, Choi SH, Smith SA. Polyphosphate: An ancient molecule that links platelets, coagulation, and inflammation. Blood 2012;119:5972–5979.
26. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 2006;103:903–908.
27. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 2011;118:6963–6970.
28. Choi SH, Smith SA, Morrissey JH. Polyphosphate accelerates factor V activation by factor XIa. Thromb Haemost 2014;113:599–604.
29. Smith SA, Morrissey JH. Polyphosphate enhances fibrin clot structure. Blood 2008;112:2810–2816.
30. Mutch NJ, Engel R, Uitte de Willige S, Philippou H, Ariens RA. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood 2010;115:3980–3988.
31. Donovan AJ, Kalkowski J, Smith SA, Morrissey JH, Liu Y. Size-controlled synthesis of granular polyphosphate nanoparticles at physiologic salt concentrations for blood clotting. Biomacromolecules 2014;15:3976–3984.
32. Kenne E, Nickel KF, Long AT, Fuchs TA, Stavrou EX, Stahl FR, Renné T. Factor XII: A novel target for safe prevention of thrombosis and inflammation. J Intern Med 2015;278:571–585.